Range Resources Case Study

1. The stakeholders of Range Resources (RR) are widespread from anyone affected by the economy and the environment in relation to RR’s activities. More directly, the stakeholders range from employees of Range Resources, the employees and officers of federal and state agencies regulating RR’s activities, to the populations in local and distant communities that are either benefiting from the products of RR’s activities or suffering from the byproducts of the same activities. Stakeholders also include the consumers of the natural gas, and the future generations who may reside in the areas affected by the fracturing (“fracking”) process.
At a higher level, RR has a responsibility to follow state and federal environmental rules & regulations as
I do not believe that the HHS can ethically determine an appropriate profit margin for Siga. The dealings and relationships between the Government agency leadership, contracts officers, negotiators and company representatives at Siga are highly suspect. The correspondence has been inappropriate between the HHS officials and the Siga reps. When the HHS officials were questioned about the inappropriate correspondence with Siga, the HHS officials have admitted and then retracted their statements. However, Siga has acknowledged the correspondence exists. Next, when HHS officials were not satisfying Siga leadership in the negotiations, Siga merely complained to Government leadership and those negotiations officials were quickly replaced. The SBA stepped in and corrected the contracting methods, stating that a Small Business (Chimerix) should be allowed to compete – the government essentially stonewalled the SBA’s findings and worked around the obstacle. Bottom line: the whole story is very fishy and I think there are way too many hands waiting to be
First off, I am questioning whether or not the Small Pox threat is actually viable. There are likely other threats that possibly pose a greater risk to the national security interests of the U.S. I believe it is time for a review of the bio-defense strategy. Ethics should never be set aside in this case but I think that testing on humans, however, does not necessarily have to be considered unethical. Perhaps there are options of eliciting volunteers that have terminal illness (a program somewhat like organ donors) where they might be able to submit themselves as test subjects for some drugs. I believe, for example, that some cancer patients will subject themselves as experimental agents for new cancer treatments. Some may find it beneficial and self-rewarding to donate their own bodies to the greater benefit of humanity and